Global Town Hall: An Opportunity for Medical Affairs Strategic Leadership During the Pandemic and Beyond

Global Town Hall: An Opportunity for Medical Affairs Strategic Leadership During the Pandemic and Beyond

July 28, 2020

OVERVIEW:

The COVID-19 pandemic is affecting Medical Affairs professionals around the world, and each team is responding in different ways. During this live Global Town Hall, we will discuss how Medical Affairs can continue to function during the COVID-19 pandemic, as well as share industry best practices and consider how Medical Affairs could change post-COVID-19. Through patient-focus and peer-to-peer relationships with HCPs, Medical Affairs professionals have a unique role in ensuring the safe and effective use of medicines, vaccines and medical devices, and are also positioned to bring invaluable insights from the field into ongoing R&D. By strengthening our understanding within the pharmaceutical industry of how Medical Affairs can support HCPs and patients in these times, this Town Hall will explore how the role of Medical Affairs can be expanded to maintain quality in a rapidly evolving clinical environment, helping to achieve industry-wide alignment on the issue and potentially saving lives.

 

Join this webinar for insights from industry-leading experts. This series including follow-on webinars will equip MAPS members and MA professionals worldwide with the tools to fulfill the opportunity for Medical Affairs strategic leadership during the Covid-19 pandemic and beyond.

 

MAPS Members have access to view and download the slides from this presentation. 

CLICK HERE TO VIEW AND DOWNLOAD SLIDES IN THE COMMUNITY PORTAL

 

 

SPEAKERS:

Rachele Berria

Vice President and Medical Head, US BioPharmaceuticals

AstraZeneca

 

Eric Mortensen

Head Gastrointestinal Clinical Development, R&D

Janssen Immunology

 

Tamas Koncz

Chief Medical Officer, Inflammation and Immunology

Pfizer

 

Isma Benattia

VP, Europe Medical Affairs

Amgen

 

Terry Griesing

VP, Head of North America Medical Affairs, Internal Medicine

Pfizer

 

Ann Hartry

VP, HEOR

Lundbeck

 

Audrey Krolicki

Senior Director, Head of Scientific Publications

Astellas

 

Danie du Plessis

Executive VP Medical Affairs

Kyowa Kirin International

 

AGENDA

Time Title speaker
9:00–9:10 EDT The Opportunity for Medical Affairs Strategic Leadership Chair: Tamas Koncz
9:10–9:20 EDT Evidence Generation: Ensuring Speed and Quality During
Rapid Decision-Making
Ann Hartry
9:20–9:30 EDT Evidence Dissemination: The New World of Publications and Virtual Congresses Audrey Krolicki
9:30–10:05 EDT Audience Q&A and Panel Discussion

What has changed for Field Medical? What hasn’t changed?

What are the needs now, and in the future?

How can the return-to-field be balanced with continued virtual interactions?

What are the key adaptive strategies, innovations and practices?

Full Expert Panel
10:05–10:15 EDT Closing: The Opportunity for MA is Here and Now Tamas Koncz